Natural products for the management of type 2 diabetes mellitus and comorbid conditions

Journal of the American Pharmacists Association

Volumn 54, Issue 5, 2014, Pages e304-e321

  Smith, Jennifer Dixon ^a   Clinard, Valerie B ^a  

^a CAMPBELL UNIVERSITY   (United States)

Author keywords

Botanicals; Diabetes; Dietary; Herbal supplements; Supplements

Indexed keywords

ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; CHROMIUM; HERBACEOUS AGENT; PYRIDOXINE; SELENIUM; THIOCTIC ACID; ZINC; BIOLOGICAL PRODUCT; GLUCOSE BLOOD LEVEL;

AMERICAN; ANTIDIABETIC ACTIVITY; ARCTIUM LAPPA; CINNAMOMUM CASSIA; CLINICAL TRIAL (TOPIC); COCCINIA GRANDIS; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; FENUGREEK; GINSENG; GYMNEMA SYLVESTRE; HUMAN; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONION; OPUNTIA; OPUNTIA STREPTACANTHA; PANAX QUINQUEFOLIUS; PLANTAGO; PLANTAGO ISPAGHULA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TARAXACUM OFFICINALE; TRADITIONAL MEDICINE; ADVERSE EFFECTS; ANIMAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; DRUG INTERACTION; GLUCOSE BLOOD LEVEL; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHYTOTHERAPY; PROCEDURES;

ANIMALS; BIOLOGICAL PRODUCTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; HUMANS; PHARMACISTS; PHYTOTHERAPY;

EID: 84907145542     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2014.14537     Document Type: Review

References (89)

1. Vuksan V, Sievenpiper JL. Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. Nutr Metab Cardiovasc Dis. 2005;15(3):149-160
2. Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United States, 2003-2006. J. Nutr. 2011;141(2):261-266
3. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988- 1994). NCHS Data Brief. 2011;61:1-8
4. Kennedy J. Herb and supplement use in the US adult population. Clin Ther. 2005;27(11):1847-1858
5. Geil P, Shane-McWhorter L. Dietary supplements in the management of diabetes: potential risks and benefits. J Am Diet Assoc. 2008;108(4 Suppl 1):S59-S65
6. Dietary Supplement Health and Education Act of 1994, PL 103-417, 108 Stat 4325
7. U.S. Food and Drug Administration. Dietary supplements. www.fda.gov/Food/DietarySupplements/default.htm. Accessed January 29, 2014
8. Yeh GY, Eisenberg DM, Kaptchuk TJ, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26(4):1277-1294
9. Shapiro K, Gong WC. Natural products used for diabetes. J Am Pharm Assoc. 2002:42(2):217-226
10. Yeh GY, Eisenberg DM, Davis RB, et al. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey. Am J Public Health. 2002;92(10):1648-1652
11. Modak M, Dixit P, Londhe J, et al. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 2007;40(3):163-173
12. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti- diabetic potential. J Ethnopharmacol. 2002;81(1):81-100
13. Garrow D, Egede LE. Association between complementary and alternative medicine use, preventive care practices, and use of conventional medical services among adults with diabetes. Diabetes Care. 2006;29(1):15-19
14. Bell RA, Suerken CK, Grzywacz JG, et al. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther in Health Med.2006;12(5):16
15. Cicero AF, Derosa G, Gaddi A. What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks. Acta Diabetol. 2004;41(3):91-98
16. Natural Standard. https://naturalmedicines.therapeuticresearch.com. Accessed January 29, 2014
17. Dans AM, Villarruz MV, Jimeno CA, et al. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J Clin Epidemiol. 2007;60(6):554-559
18. Fuangchan A, Sonthisombat P, Seubnukarn T, et al. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol. 2011;134(2):422-428
19. Chan, YS, Cheng LN, Wu JH, et al. A review of the pharmacological effects of Arctium lappa (burdock). Inflammopharmacology. 2011;19(5):245-254
20. Nahas R, Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician. 2009;55(6):591-596
21. Suksomboon N, Poolsup N, Boonkaew S, et al. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. J Ethnopharmacol. 2011;137(3):1328-1333
22. Allen RW, Schwartzman E, Baker WL, et al. Cinnamon use in type 2 diabetes: An updated systematic review and metaanalysis. Ann Fam Med. 2013;11(5):452-459
23. Khan A, Safdar M, Ali Khan MM, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26(12):3215-3218
24. Leach MJ, Kumar S. Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 2012;9:CD007170
25. Goksu E, Eken C, Karadeniz O, et al. First report of hypoglycemia secondary to dandelion (Taraxacum officinale) ingestion. Am J Emerg Med. 2010;28(1):111.e1-111.e2
26. Neelakantan N, Narayanan M, de Souza RJ, et al. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: A meta-analysis of clinical trials. Nutr J. 2014;13:7
27. Hays NP, Galassetti PR, Coker RH. Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther. 2008;118(2):181-191
28. Vuksan V, Sung MK, Sievenpiper JL, et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovas Dis. 2008;18(1):46-56
29. Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol. 1990;30(3):295-300
30. Kuriyan R, Rajendran R, Bantwal G, et al. Effect of supplementation of Coccinia cordifolia extract on newly detected diabetic patients. Diabetes Care. 2008;31(2):216-220
31. Shekelle PG, Hardy M, Morton SC, et al. Are Ayurvedic herbs for diabetes effective? J Fam Pract. 2005;54(10):876-886
32. Kamble SM, Jyotishi GS, Kamalakar PL, et al. Efficacy of Coccinia indica W & A in diabetes mellitus. J Res Ayur Sid. 1996;17:77-84
33. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(Suppl 1):s14-s80
34. Hall M, Flinkman T. Do fiber and psyllium fiber improve diabetic metabolism? Consult Pharm. 2012;27(7):513-516
35. AbouZid SF, Ahmed OM, Ahmed RR, et al. Antihyperglycemic effect of crude extracts of some Egyptian plants and algae. J Med Food. 2014;17(3):400-406
36. Anderson JW, Allgood LD, Turner J, et al. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr. 1999;70(4):466-473
37. Ziai SA, Larijani B, Akhoondzadeh S, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005;102(2):202-207
38. Natural Medicines Comprehensive Database. http://naturaldatabase. therapeuticresearch.com. Accessed February 1, 2014
39. Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365-2370
40. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A meta-analysis. Diabet Med. 2004;21(2):114-121
41. Konrad T, Vicini P, Kusterer K, et al. Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care. 1999;22(2):280-287
42. Jacob S, Henriksen EJ, Schiemann AL, et al. Enhancement of glucose disposal in patients with type 2 diabetes by alphalipoic acid. Arzneimittelforschung. 1995;45(8):872-874
43. Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo-controlled pilot trial. Free Radic Biol Med. 1999;27:309-314
44. Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha- lipoic acid. Hormones. 2006;5(4):251-258
45. Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: A systematic review. Ophthalmic Physiol Opt. 2008;28(6):503-523
46. Mazloom Z, Ansar H. The effect of alpha-lipoic acid on blood pressure in type 2 diabetics. Iran J Endocrinol Metab. 2009;11(3):245-250
47. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alphalipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study). Diabetes Care. 1999;22(8):1296-1301
48. Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alphalipoic acid): A two year multicenter randomized doubleblind placebo-controlled trial (ALADIN II). Free Radic Res. 1999;31(3):171-179
49. Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003;26(3):770-776
50. McIIduff CE, Rutkove SB. Critical appraisal of the use of alpha lipoic acid (thiotic acid) in the treatment of symptomatic diabetic polyneuropathy. Ther Clin Risk Manag. 2011;7:377-385
51. Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes. 1997;46(Suppl 2):S62-S66
52. Han T, Bai J, Liu W, et al. A systematic review and metaanalysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol. 2012;167(4):465-471
53. Haritoglou C, Gerss J, Hammes HP, et al. Alpha-lipoic acid for the prevention of diabetic macular edema. Ophthalmologica. 2011;226(3):127-137
54. de Oliveira AM, Rondo PH, Luzia LA, et al. The effects of lipoic acid and alpha-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Diabetes Res Clin Pract. 2011;92(2):253-260
55. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med. 1997;336(17):1216-1222
56. Montonen J, Knekt P, Jarvinen R, et al. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care. 2004;27(2):362-366
57. Arnlov J, Zethelius B, Riserus U, et al. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study. Diabetologia. 2009;52(1):97-105
58. Bursell SE, Clermont AC, Aiello LP, et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care. 1999;22(8):1245-1251
59. Tutuncu NB, Bayraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: A preliminary study. Diabetes Care. 1998;21(11):1915-1918
60. Paolisso G, D'Amore A, Giugliano D, et al. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr. 1993;57(5):650-656
61. Blum S, Vardi M, Brown JB, et al. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics. 2010;11(5):675-684
62. Vardi M, Blum S, Levy AP. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus- natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur J Intern Med. 2012;23(7):628-632
63. Suksomboon N, Poolsup N, Sinprasert S. Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials. J Clin Pharm Ther. 2011;36(1):53-63
64. Gomez-Perez FJ, Valles-Sanchez VE, Lopez-Alvarenga JC, et al. Vitamin E modifies neither fructosamine nor HbA1c levels in poorly controlled diabetes. Rev Invest Clin. 1996;48(6):421-424
65. Ble-Castillo JL, Carmona-Diaz E, Mendez JD, et al. Effect of alpha-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics. Biomed Pharmacother. 2005;59(6):290-295
66. Kataja-Tuomola M, Sundell JR, Mannisto S, et al. Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. Diabetologia. 2008;51(1):47-53
67. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med. 2000;342(3):154-160
68. Albarracin CA, Fuqua BC, Evans JL, et al. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev. 2008;24(1):41-51
69. Balk EM, Tatsioni A, Lichtenstein AH, et al. Effect of chromium supplementation on glucose metabolism and lipids: A systematic review of randomized controlled trials. Diabetes Care. 2007;30(8):2154-2163
70. Kleefstra N, Houweling ST, Jansman FG, et al. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: A randomized, double-blind, placebo-controlled trial. Diabetes Care. 2006;29(3):521-525
71. Kleefstra N, Houweling ST, Bakker SJ, et al. Chromium treatment has no effect in patients with type 2 diabetes in a Western population: A randomized, double-blind, placebocontrolled trial. Diabetes Care. 2007;30(5):1092-1096
72. Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: A placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther. 2006;8(6):636-643
73. Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46(11):1786-1791
74. Pei D, Hsieh CH, Hung YJ, et al. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: A randomized, double-blind, placebo- controlled trial. Metabolism. 2006;55(7):923-927
75. Krol E, Krejpcio Z, Byks H, et al. Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients. Biol Trace Elem Res. 2011;143(2):726-737
76. Jain SK, Kahlon G, Morehead L, et al. Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-alpha, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebocontrolled study. Mol Nutr Food Res. 2012;56(8):1333-1341
77. Althuis MD, Jordan NE, Ludington EA, et al. Glucose and insulin responses to dietary chromium supplements: A metaanalysis. Am J Clin Nutr. 2002;76(1):148-155
78. Head KA. Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern Med Rev. 2006;11(4):294-329
79. Levin ER, Hanscom TA, Fisher M, et al. The influence of pyridoxine in diabetic peripheral neuropathy. Diabetes Care. 1981;4(6):606-609
80. Abbas ZG, Swai AB. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr Med J. 1997;74(12):803-808
81. Rao RH. Glucose tolerance in subclinical pyridoxine deficiency in man. Am J Clin Nutr. 1983;38(3):440-444
82. Rao RH, Vigg BL, Rao KS. Failure of pyridoxine to improve glucose tolerance in diabetics. J Clin Endocrinol Metab. 1980;50(1):198-200
83. Stranges S, Marshall JR, Natarajan R, et al. Effects of longterm selenium supplementation on the incidence of type 2 diabetes: A randomized trial. Ann Intern Med. 2007;147(4):217-223
84. Bleys J, Miller ER III, Pastor-Barriuso R, et al. Vitamin-mineral supplementation and the progression of atherosclerosis: A meta-analysis of randomized controlled trials. Am J Clin Nutr. 2006;84(4):880-887
85. Akbaraly TN, Arnaud J, Rayman MP, et al. Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutr Metab. 2010;7:21
86. Blostein-Fujii A, DiSilvestro RA, Frid D, et al. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5'-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Am J Clin Nutr. 1997;66(3):639-642
87. Tang X, Shay NF. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr. 2001;131(5):1414-1420
88. Dennehy CE, Tsourounis C, Horn AJ. Dietary supplement-related adverse events reported to the California Poison Control System. Am J Health Syst Pharm. 2005;62(14):1476-1482
89. Gupta R, Garg VK, Mathur DK, et al. Oral zinc therapy in diabetic neuropathy. J Assoc Physicians India. 1998;46(11):939-942